On-Demand Webinar

On-Demand Webinar

Learn More About the Speakers

Marco Tangelder, MD

Marco Tangelder, MD, PhD, Senior Medical Director, Medpace

Dr. Marco Tangelder is a clinical epidemiologist with 25+ years of academic, pharmaceutical and biotech industry experience with a strong background in thrombosis and hemostasis research, development of anti-thrombotic therapies for a broad range of indications, and development of gene therapy for hemophilia and ophthalmology. Prior to joining Medpace in 2017, Dr. Tangelder held key roles in various biotechnology and pharmaceutical companies where he was responsible for translational medicine, phase 1-4 clinical development programs and regulatory approvals. Most recently, he led the clinical development of gene therapy for hemophilia and contributed to preclinical development and translational research of gene therapy constructs for various rare disease indications. Dr. Tangelder received both his medical degree and PhD at the University of Utrecht in the Netherlands and received his Master’s in Pharmaceutical Medicine at the Karolinska Institutet in Stockholm, Sweden.

Todd BanksTodd Banks, PharmD, RPh. Director of Regulatory Affairs and Regulatory Intelligence, Medpace

Dr. Todd Banks is a clinical pharmacist with 34+ years of experience in the pharmaceutical industry with a strong background and knowledge in pharmacotherapeutics and FDA regulatory sciences. His healthcare experience is comprehensive and encompasses the complete product life-cycle from product development and formulation, to medical affairs and human safety, pharmacovigilance and regulatory affairs. The breadth of his experience spans cosmetics, medical devices, and non-prescription and prescription medications. He has led numerous scientific advisory meetings on first-in-class product innovations, has provided regulatory support for three successful Rx-to-OTC drug switches, obtained FDA market authorization for the first cleared direct-to-consumer photoepilation medical device and has successfully led numerous pre-IND and IND drug programs in a variety of therapeutic areas, including ultra rare diseases. He is a registered pharmacist, holds a doctorate degree in Clinical Pharmacy with undergraduate degrees in instrumental chemistry, organic chemistry, natural science and pharmacy, all from the University of Cincinnati.

Madhavi MalladiMadhavi Malladi, PhD, Clinical Trial Manager, Medpace

Madhavi Malladi has 6+ years of clinical research experience which includes working on trials involving advanced therapies for rare disease indications. Prior to joining Medpace, she was an Assistant Research Director at New York Presbyterian/Queens. She has a PhD in Cell and Molecular Biology from The University of Texas at Austin. She completed her Postdoctoral Fellowship in Cancer genetics at Herbert Irving Cancer Center at Colombia University, focusing on molecular classification of diffuse large B-cell lymphomas using transcriptome profiling, next generation sequencing and RNAi technologies. Her therapeutic experience includes ophthalmology, hematology and oncology, cardiovascular, endocrine disorders, obstetrics/gynecology and neonatology.

Contact us to learn more about rare disease clinical research